Senator Patty Murray Criticizes Trump Administration's Cuts to Diabetes Research Grants

Concerns Over NIH Grant Cancellations

• ⚠️ Senator Patty Murray expresses significant concern regarding the Trump administration's decision to terminate or freeze over 260 grants from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
• 🎯 Four of these canceled grants are located in her home state of Washington, impacting a clinical trial for hemodialysis patients and a program to train future researchers.

Impact on Type 1 Diabetes Research

• 💡 The NIH Special Diabetes Program supports critical, life-changing research for millions living with type 1 diabetes, including advancements like artificial pancreas devices and new medications.
• 🔬 Funding cuts jeopardize ongoing research, such as a study at Columbia University on how type 1 diabetes affects bone strength in children, which is vital for their development and ability to participate in activities.

Congressional Authority and Advocacy

• 🏛️ Senator Murray emphasizes that Congress, not the President, determines funding for diabetes research, and highlights commitment from both parties to maintain investments.
• 🗣️ She urges for action beyond mere discussion, calling to reject the administration's actions against biomedical research at the NIH.
• 📣 The senator stresses the power of voices, particularly those of advocates and individuals with diabetes, in defending research and pushing back against funding cuts.

Importance of Patient Voices

• 🌟 The presence of children and young adults living with type 1 diabetes at the hearing underscores the personal impact of this disease and the importance of their stories in motivating congressional action.
• 🌱 Sharing personal experiences is identified as the most effective tool for advocates to highlight what is at stake and ensure continued investment in research aimed at treating and eventually curing type 1 diabetes.